Chronic treatment-related pain in cancer survivors

Pain

Volumn 152, Issue SUPPL.3, 2011, Pages

  Paice, Judith A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Arthralgias; Cancer pain; Chemotherapy induced peripheral neuropathy; Graft vs. host disease; Plexopathy

Indexed keywords

ANASTROZOLE; ARMIDEX; AROMATASE INHIBITOR; BORTEZOMIB; CARBOPLATIN; CHONDROITIN; CISPLATIN; DOCETAXEL; ERGOCALCIFEROL; ETHOSUXIMIDE; EXEMESTANE; GLUCOSAMINE; IXABEPILONE; LENALIDOMIDE; LETROZOLE; LEVACECARNINE; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; OLESOXIME; OMEGA 3 FATTY ACID; OPIATE; OXALIPLATIN; PACLITAXEL; PARACETAMOL; PLACEBO; PROBIOTIC AGENT; TESTOSTERONE; THALIDOMIDE; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE;

ACUPUNCTURE; ARTHRALGIA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHEMOTHERAPY INDUCED PAINFUL PERIPHERAL NEUROPATHY; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC PAIN; DRUG MEGADOSE; EXERCISE; HUMAN; LONG TERM CARE; MULTIPLE MYELOMA; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; REVIEW;

ANALGESICS; CHRONIC DISEASE; HUMANS; NEOPLASMS; PAIN; PALLIATIVE CARE; SURVIVORS; SYNDROME; TERMINAL CARE;

EID: 79951580799     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.10.010     Document Type: Review

References (73)

1. N. Attal, D. Bouhassira, M. Gautron, J.N. Vaillant, E. Mitry, C. Lepere, P. Rougier, and F. Guirimand Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study Pain 144 2009 245 252
2. D. Barton, E. Wos, R. Qin, B. Mattar, N. Green, K. Lanier, J. Bearden, J. Kugler, K. Hoff, P. Reddy, K. Rowland, M. Riepl, B. Christensen, and C. Loprinzi A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA Support Care Cancer 23 2010 1 9
3. M. Baum, A. Buzdar, J. Cuzick, J. Forbes, J. Houghton, A. Howell, and T. Sahmoud ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' group. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses Cancer 98 2003 1802 1810 (Pubitemid 37310221)
4. N.N. Baxter, E.B. Habermann, J.E. Tepper, S.B. Durham, and B.A. Virnig Risk of pelvic fractures in older women following pelvic irradiation JAMA 294 2005 2587 2593 (Pubitemid 41697248)
5. S.N. Birrell, and W. Tilley Testosterone undecanoate treatment reduces joint morbidities induced by anastrozole therapy in postmenopausal women with breast cancer: Results of a double-blind, randomized phase II trial Cancer Res 69 2009 804
6. Boyle P, Levin B. World cancer report 2008. Lyon: International Agency for Research on Cancer; 2008.
7. H.J. Burstein, and E.P. Winer Aromatase inhibitors and arthralgias: a new frontier in symptom management for breast cancer survivors J Clin Oncol 25 2007 3797 3799 (Pubitemid 47477251)
8. A.W. Burton, G.J. Fanciullo, R.D. Beasley, M.J. Fisch, A.W. Burton, G.J. Fanciullo, R.D. Beasley, and M.J. Fisch Chronic pain in the cancer survivor: a new frontier Pain Med 8 2007 189 198
9. J.P. Cata, J.V. Cordella, A.W. Burton, S.J. Hassenbusch, H.R. Weng, and P.M. Dougherty Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report J Pain Symptom Manage 27 2004 72 78 (Pubitemid 38050250)
10. J.P. Cata, H.R. Weng, A.W. Burton, H. Villareal, S. Giralt, and P.M. Dougherty Quantitative sensory findings in patients with bortezomib-induced pain J Pain 8 2007 296 306 (Pubitemid 46551871)
11. J.P. Cata, H.R. Weng, P.M. Dougherty, J.P. Cata, H.-R. Weng, and P.M. Dougherty Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy Brain Res 1230 2008 91 98
12. G. Cavaletti, B. Frigeni, F. Lanzani, L. Mattavelli, E. Susani, P. Alberti, D. Cortinovis, and P. Bidoli Chemotherapy-Induced peripheral neurotoxicity assessment: a critical revision of the currently available tools Eur J Cancer 46 2010 479 494
13. R.E. Coleman, W.W. Bolten, M. Lansdown, S. Dale, C. Jackisch, D. Merkel, N. Maass, and P. Hadji Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations Cancer Treat Rev 34 2008 275 282
14. K.D. Crew, J.L. Capodice, H. Greenlee, L. Brafman, D. Fuentes, D. Awad, W. Yann Tsai, and D.L. Hershman Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer J Clin Oncol 28 2010 1154 1160
15. K.D. Crew, H. Greenlee, J. Capodice, G. Raptis, L. Brafman, D. Fuentes, A. Sierra, and D.L. Hershman Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer J Clin Oncol 25 2007 3877 3883 (Pubitemid 47477264)
16. C. Cutler, S. Giri, S. Jeyapalan, D. Paniagua, A. Viswanathan, and J.H. Antin Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis J Clin Oncol 19 2001 3685 3691 (Pubitemid 32786281)
17. M.E. Dawson-Basoa, and A.R. Gintzler Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms Pain 64 1996 169 177
18. P.P. Donnellan, S.L. Douglas, D.A. Cameron, and R.C. Leonard Aromatase inhibitors and arthralgia J Clin Oncol 19 2001 2767
19. P.M. Dougherty, J.P. Cata, A.W. Burton, K. Vu, and H.R. Weng Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain J Pain Symptom Manage 33 2007 166 179 (Pubitemid 46186866)
20. P.M. Dougherty, J.P. Cata, J.V. Cordella, A. Burton, and H.R. Weng Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients Pain 109 2004 132 142 (Pubitemid 38479779)
21. E.J. Dropcho, and E.J. Dropcho Neurotoxicity of radiation therapy Neurol Clin 28 2010 217 234
22. E. Fathers, D. Thrush, S.M. Huson, and A. Norman Radiation-induced brachial plexopathy in women treated for carcinoma of the breast Clin Rehabil 16 2002 160 165 (Pubitemid 34187843)
23. D.T. Felson, and S.R. Cummings Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation Arthritis Rheum 52 2005 2594 2598 (Pubitemid 41369086)
24. M. Fimiani, G. De Aloe, and A. Cuccia Chronic graft versus host disease and skin J Eur Acad Dermatol Venereol 17 2003 512 517 (Pubitemid 37138886)
25. S.J. Flatters, and G.J. Bennett Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy Pain 109 2004 150 161 (Pubitemid 38479781)
26. S.J. Flatters, and G.J. Bennett Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction Pain 122 2006 245 257 (Pubitemid 43729476)
27. S.J. Flatters, W.H. Xiao, and G.J. Bennett Acetyl-l-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy Neurosci Lett 397 2006 219 223
28. M.E. Flowers, P.M. Parker, L.J. Johnston, A.V. Matos, B. Storer, W.I. Bensinger, R. Storb, F.R. Appelbaum, S.J. Forman, K.G. Blume, and P.J. Martin Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial Blood 100 2002 415 419 (Pubitemid 34761101)
29. B. Friedrichs, A. Tichelli, A. Bacigalupo, N.H. Russell, T. Ruutu, and M.Y. Shapira Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial Lancet Oncol 11 2010 331 338
30. S. George, A. Brenner, J. Sarantopoulos, and R. Bukowski RANK ligand: effects of inhibition Curr Oncol Rep 12 2010 80 86
31. P.E. Goss, J.N. Ingle, S. Martino, N.J. Robert, H.B. Muss, M.J. Piccart, M. Castiglione, D. Tu, L.E. Shepherd, K.I. Pritchard, R.B. Livingston, N.E. Davidson, L. Norton, E.A. Perez, J.S. Abrams, P. Therasse, M.J. Palmer, and J.L. Pater A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 349 2003 1793 1802 (Pubitemid 37362955)
32. G. Gutierrez-Gutierrez, M. Sereno, A. Miralles, E. Casado-Saenz, and E. Gutierrez-Rivas Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies Clin Transl Oncol 12 2010 81 91
33. J.E. Hammack, J.C. Michalak, C.L. Loprinzi, J.A. Sloan, P.J. Novotny, G.S. Soori, M.T. Tirona, K.M. Rowland Jr., P.J. Stella, and J.A. Johnson Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy Pain 98 2002 195 203 (Pubitemid 34722482)
34. C.M. Harper Jr, J.E. Thomas, T.L. Cascino, and W.J. Litchy Distinction between neoplastic and radiation-induced brachial plexopathy, with emphasis on the role of EMG Neurology 39 1989 502 506 (Pubitemid 19105763)
35. F.H. Hausheer, R.L. Schilsky, S. Bain, E.J. Berghorn, and F. Lieberman Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy Semin Oncol 33 2006 15 49 (Pubitemid 43214485)
36. N.L. Henry, J.T. Giles, D. Ang, M. Mohan, D. Dadabhoy, J. Robarge, J. Hayden, S. Lemler, K. Shahverdi, P. Powers, L. Li, D. Flockhart, V. Stearns, D.F. Hayes, A.M. Storniolo, and D.J. Clauw Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors Breast Cancer Res Treat 111 2008 365 372
37. M.E. Horwitz, and K.M. Sullivan Chronic graft-versus-host disease Blood Rev 20 2006 15 27 (Pubitemid 43106715)
38. A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett, J.F. Forbes, G. Hoctin-Boes, J. Houghton, G.Y. Locker, and J.S. Tobias ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 2005 60 62
39. K.A. Jaeckle Neurologic manifestations of neoplastic and radiation-induced plexopathies Semin Neurol 30 2010 254 262
40. P. Kanavos The rising burden of cancer in the developing world Ann Oncol 17 2006 15 23
41. V. Kataja, and M. Castiglione ESMO guidelines working group. Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 20 2009 10 14
42. A.L. Kautio, M. Haanpaa, T. Saarto, and E. Kalso Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms J Pain Symptom Manage 35 2008 31 39 (Pubitemid 350299098)
43. S.H. Kori, K.M. Foley, and J.B. Posner Brachial plexus lesions in patients with cancer: 100 cases Neurology 31 1981 45 50 (Pubitemid 11217452)
44. M.H. Levy, M. Chwistek, R.S. Mehta, M.H. Levy, M. Chwistek, and R.S. Mehta Management of chronic pain in cancer survivors Cancer J 14 2008 401 409
45. J.J. Mao, C. Stricker, D. Bruner, S. Xie, M.A. Bowman, J.T. Farrar, B.T. Greene, and A. DeMichele Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors Cancer 115 2009 3631 3639
46. E. McCloskey Effects of third-generation aromatase inhibitors on bone Eur J Cancer 42 2006 1044 1051
47. C. Meregalli, A. Canta, V.A. Carozzi, A. Chiorazzi, N. Oggioni, A. Gilardini, C. Ceresa, F. Avezza, L. Crippa, P. Marmiroli, and G. Cavaletti Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats Eur J Pain 14 2010 343 350
48. W.R. Miller, R.A. Hawkins, and A.P. Forrest Significance of aromatase activity in human breast cancer Cancer Res 42 1982 3365s 3368s (Pubitemid 12022725)
49. R.K. Murthy, P.K. Morrow, and R.L. Theriault Bone biology and the role of the RANK ligand pathway Oncology (Williston) 23 2009 9 15
50. A.A. Muslimani, T.P. Spiro, A.A. Chaudhry, H.C. Taylor, I. Jaiyesimi, and H.A. Daw Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Clin Breast Cancer 9 2009 34 38
51. N.K. Olsen, P. Pfeiffer, L. Johannsen, H. Schroder, and C. Rose Radiation-induced brachial plexopathy: neurological follow-up in 161 recurrence-free breast cancer patients Int J Radiat Oncol Biol Phys 26 1993 43 49 (Pubitemid 23137886)
52. F. Pansini, P. Albertazzi, G. Bonaccorsi, M. Calisesi, C. Campobasso, L. Zanotti, B. Bagni, and G. Mollica The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints Eur J Obstet Gynecol Reprod Biol 57 1994 103 109 (Pubitemid 24353513)
53. A.H. Partridge, A. LaFountain, E. Mayer, B.S. Taylor, E. Winer, and A. Asnis-Alibozek Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer J Clin Oncol 26 2008 556 562 (Pubitemid 351264348)
54. R. Powles 50 years of allogeneic bone-marrow transplantation Lancet Oncol 11 2010 305 306
55. R.D. Rao, P.J. Flynn, J.A. Sloan, G.Y. Wong, P. Novotny, D.B. Johnson, H.M. Gross, S.I. Renno, M. Nashawaty, and C.L. Loprinzi Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3 Cancer 112 2008 2802 2808 (Pubitemid 351969227)
56. R.D. Rao, J.C. Michalak, J.A. Sloan, C.L. Loprinzi, G.S. Soori, D.A. Nikcevich, D.O. Warner, P. Novotny, L.A. Kutteh, and G.Y. Wong North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3) Cancer 110 2007 2110 2118
57. A. Rastelli, M. Taylor, R. Villareal, S. Jamalabadi-Majidi, F. Gao, and M. Ellis A double-blind, randomized, placebo-controlled trial of high dose vitamin D therapy on musculoskeleteal pain and bone mineral density in anastrozole-treated breast cancer patients with marginal vitamin D status Cancer Res 69 2009 803
58. P.G. Richardson, H. Briemberg, S. Jagannath, P.Y. Wen, B. Barlogie, J. Berenson, S. Singhal, D.S. Siegel, D. Irwin, M. Schuster, G. Srkalovic, R. Alexanian, S.V. Rajkumar, S. Limentani, M. Alsina, R.Z. Orlowski, K. Najarian, D. Esseltine, K.C. Anderson, and A.A. Amato Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib J Clin Oncol 24 2006 3113 3120 (Pubitemid 46638949)
59. J.D. Rizzo, R.E. Curtis, G. Socie, K.A. Sobocinski, E. Gilbert, O. Landgren, L.B. Travis, W.D. Travis, M.E. Flowers, D.L. Friedman, M.M. Horowitz, J.R. Wingard, and H.J. Deeg Solid cancers after allogeneic hematopoietic cell transplantation Blood 113 2009 1175 1183
60. G. Roth, M.R. Magistris, D. Le Fort, P. Desjacques, and D. Della Santa Post-radiation brachial plexopathy. Persistent conduction block. Myokymic discharges and cramps Rev Neurol 144 1988 173 180 (Pubitemid 18098657)
61. I. Sestak, J. Cuzick, F. Sapunar, R. Eastell, J.F. Forbes, A.R. Bianco, and A.U. Buzdar Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis Lancet Oncol 9 2008 866 872
62. C. Siau, and G.J. Bennett Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy Anesth Analg 102 2006 1485 1490
63. C. Siau, W. Xiao, and G.J. Bennett Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells Exp Neurol 201 2006 507 514 (Pubitemid 44344243)
64. G. Socie, J.V. Stone, J.R. Wingard, D. Weisdorf, P.J. Henslee-Downey, C. Bredeson, J.Y. Cahn, J.R. Passweg, P.A. Rowlings, H.C. Schouten, H.J. Kolb, and J.P. Klein Long-term survival and late deaths after allogeneic bone marrow transplantation. Late effects working committee of the international bone marrow transplant registry N Engl J Med 341 1999 14 21
65. M.D. Stubblefield, H.J. Burstein, A.W. Burton, C.M. Custodio, G.E. Deng, M. Ho, L. Junck, G.S. Morris, J.A. Paice, S. Tummala, and J.H. Von Roenn NCCN task force report: management of neuropathy in cancer JNCCN 7 Suppl 5 2009 S1 S26
66. M.J. Teixeira, E.T. Fonoff, and M.C. Montenegro Dorsal root entry zone lesions for treatment of pain-related to radiation-induced plexopathy Spine 32 2007 E316 319
67. A. Tyndall, F. Dazzi, A. Tyndall, and F. Dazzi Chronic GVHD as an autoimmune disease Best Pract Res Clin Haematol 21 2008 281 289 (Pubitemid 351712722)
68. E. Vargas-Diez, A. Garcia-Diez, A. Marin, and J. Fernandez-Herrera Life-threatening graft-vs-host disease Clin Dermatol 23 2005 285 300 (Pubitemid 40724462)
69. A.C. Vigorito, P.V. Campregher, B.E. Storer, P.A. Carpenter, C.K. Moravec, H.P. Kiem, M.L. Fero, E.H. Warren, S.J. Lee, F.R. Appelbaum, P.J. Martin, and M.E. Flowers National Institutes of Health. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD Blood 114 2009 702 708
70. S. Wolf, D. Barton, L. Kottschade, A. Grothey, and C. Loprinzi Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies Eur J Cancer 44 2008 1507 1515
71. W. Xiao, A. Boroujerdi, G.J. Bennett, and Z.D. Luo Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit Neuroscience 144 2007 714 720 (Pubitemid 44856756)
72. W. Xiao, L. Naso, and G.J. Bennett Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies Pain Med 9 2008 505 517
73. W.H. Xiao, and G.J. Bennett Chemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-l-carnitine Pain 135 2008 262 270 (Pubitemid 351330186)